4 research outputs found

    Synthesis, Characterization, and X‑ray Attenuation Properties of Ultrasmall BiOI Nanoparticles: Toward Renal Clearable Particulate CT Contrast Agents

    No full text
    A unique decelerated hydrolytic procedure is developed and reported here for the preparation of ultrasmall nanoparticles (NPs) of PVP-coated BiOI with a narrow size distribution, i.e., 2.8 ± 0.5 nm. The crystal structure of this compound is determined by X-ray powder diffraction using the bulk materials. The stability, cytotoxicity, and potential use of the PVP-coated ultrasmall BiOI NPs as a CT contrast agent are investigated. Because of the combined X-ray attenuation effect of bismuth and iodine, such NPs exhibit a CT value that is among the best of those of the inorganic nanoparticle-based CT contrast agents reported in the literature

    Synthesis, Characterization, and X‑ray Attenuation Properties of Ultrasmall BiOI Nanoparticles: Toward Renal Clearable Particulate CT Contrast Agents

    No full text
    A unique decelerated hydrolytic procedure is developed and reported here for the preparation of ultrasmall nanoparticles (NPs) of PVP-coated BiOI with a narrow size distribution, i.e., 2.8 ± 0.5 nm. The crystal structure of this compound is determined by X-ray powder diffraction using the bulk materials. The stability, cytotoxicity, and potential use of the PVP-coated ultrasmall BiOI NPs as a CT contrast agent are investigated. Because of the combined X-ray attenuation effect of bismuth and iodine, such NPs exhibit a CT value that is among the best of those of the inorganic nanoparticle-based CT contrast agents reported in the literature

    Selective Ion Exchange Governed by the Irving–Williams Series in K<sub>2</sub>Zn<sub>3</sub>[Fe(CN)<sub>6</sub>]<sub>2</sub> Nanoparticles: Toward a Designer Prodrug for Wilson’s Disease

    No full text
    The principle of the Irving–Williams series is applied to the design of a novel prodrug based on K<sub>2</sub>Zn<sub>3</sub>[Fe­(CN)<sub>6</sub>]<sub>2</sub> nanoparticles (ZnPB NPs) for Wilson’s disease (WD), a rare but fatal genetic disorder characterized by the accumulation of excess copper in the liver and other vital organs. The predetermined ion-exchange reaction rather than chelation between ZnPB NPs and copper ions leads to high selectivity of such NPs for copper in the presence of the other endogenous metal ions. Furthermore, ZnPB NPs are highly water-dispersible and noncytotoxic and can be readily internalized by cells to target intracellular copper ions for selective copper detoxification, suggesting their potential application as a new-generation treatment for WD

    Gallium Analogue of Soluble Prussian Blue KGa[Fe(CN)<sub>6</sub>]·<i>n</i>H<sub>2</sub>O: Synthesis, Characterization, and Potential Biomedical Applications

    No full text
    The gallium analogue of the soluble Prussian blue with the formula KGa­[Fe­(CN)<sub>6</sub>]·<i>n</i>H<sub>2</sub>O is synthesized and structurally characterized. A simple aqueous synthetic procedure for preparing nanoparticles of this novel coordination polymer is reported. The stability, in vitro ion exchange with ferrous ions, cytotoxicity, and cellular uptake of such nanoparticles coated with poly­(vinylpyrrolidone) are investigated for potential applications of delivering Ga<sup>3+</sup> ions into cells or removing iron from cells
    corecore